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Examination of the three-dimensional structure of Erythrina corallodendron lectin (ECorL) in complex with a ligand (lactose), the first of its kind 
for a Gal/GalNAc-specific lectin [(1991) Science 254, 862-8661, revealed the presence of a hydrophobic cavity, surrounded by Tyr”“’ and Prol”- 
Trp”‘, which can accommodate bulky substituents uch as acetamido r dansylamido (NDns) at C-2 of the lectin-bound galactose. Comparison 
of the primary sequence of ECorL with that of soybean agglutinin, specific for galactose and its C-2 substituted erivatives, and ofpeanut agglutinin, 
specific for galactose only, showed that in soybean agglutinin, Tyr”’ is retained, and Pro’34-Trp’35 is replaced by Ser-Trp, whereas in peanut 
agglutinin, the former residue is replaced by Thr and the dipeptide by Ser-Glu-Tyr-Asn. Three mutants of ECorL were therefore constructed: 
L2, in which Pro’34-Trp’35 was replaced by Ser-Glu-Tyr-Asn; YlO8T, in which Tyr” was replaced by Thr and the double mutant L2; Y108T. 
They were expressed in Escherichiu co/i, as done for recombinant ECorL [(1992) Eur. J. Biochem. 205, 575-5811. The mutants had the same 
hemagglutinating activity as native or rECorL. Their specificity for galactose, GalNAc and MepGalNDns was examined by inhibition of 
hemagglutination and of the binding of the lectin to immobilized asialofetuin; in addition, their association constants with MeaGalNDns and 
Me/JGalNDns were measured by spectrofluorimetric titration. The results showed that Yl08T had essentially similar specificity as the native and 
recombinant lectins. The affinity of L2 and L2;Yl08T for galactose was also the same as ECorL, but they had a lower affinity for GalNAc and 
markedly diminished affinity for the dansyl sugars (up to 43 times, or 2 kcal, less). This appears to be largely due to steric hindrance by the two 
additional amino acids present in the cavity region in these mutants. Our findings also provide an explanation for the inability of PNA to 
accommodate C-2-substituted galactose derivatives at its primary subsite. 
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1. INTRODUCTION 
Legume lectins exhibit a considerable degree of se- 
quence homology [1,2] and, to the extent examined, 
possess nearly superimposable tertiary structures [3-51, 
but they differ in their carbohydrate specificities. For 
example, lectins of this family that are specific for galac- 
tose differ considerably in their relative affinity for 2- 
substituted galactose derivatives. Thus, Erythrina coral- 
lodendron lectin (ECorL) binds N-acetylgalactosamine 
slightly better than galactose and shows a strong prefer- 
ence for N-dansylgalactosamine [6,7]; soybean aggluti- 
nin (SBA) binds the former monosaccharide considera- 
bly better than galactose, and shows also pronounced 
preference for N-dansylgalactosamine [8], whereas pea- 
nut agglutinin (PNA) does not bind N-acetylgalacto- 
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samine or N-dansylgalactosamine in its primary subsite 
[9,101. 
Examination of the three-dimensional structure of 
the ECorL-lactose complex [3] gives us some clues to 
understand the structural basis of the above mentioned 
differences. An open space or cavity can be seen, close 
to the 2-OH of the bound galactose, that could readily 
accommodate bulky substituents (Fig. 1). This space is 
bordered by Gly107-Tyr108 (loop 1) and Asn’33-Pro134- 
Trp135-Asp136 (loop 2). Asn133 and Asp136 are invariant 
in all the known primary sequences of the legume lectins 
and Gly”’ in most of them [ 1,2,11,12]. Moreover, these 
residues occupy identical positions in the three-dimen- 
sional structures examined to date [3,5]. It is therefore 
unlikely that they are responsible for the differences in 
sugar specificity. Although the three-dimensional struc- 
tures of SBA and PNA are not yet known, comparison 
of their primary sequences [ 1 l-131 with that of ECorL 
[14,15] shows differences in the regions of the above 
mentioned loops (Fig. 1). In loop 1, Tyr108 in ECorL is 
retained in SBA, but in PNA it is replaced by threonine. 
In loop 2, the main difference is the presence of two 
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Loop 1 108 
ECorL GY&# 
SBA HAcjY 
PNA GGGT 
Loop 2 135 
;;irL FS[JP-W-D 
FF.PiS-W-D 
PNA YSNSEYND 
Fig. 1. Region of the combining site of ECorL with bound galactose, 
based on the 3D structure of the l&in-lactose complex [3]. Hydrogen 
bonds are indicated by dashed lines. Side chains of residues that may 
be in contact with buky substituents at the C-2 of galactose are shad- 
owed. The insets present he sequences of loop 1 and loop 2 in ECorL, 
where mutations were done, and the homologous residues in SBA [13] 
and PNA [11,12] (shadowed). 
extra amino acids in PNA. In order to test which of 
these may account for the differences in specificity of 
these lectins for galactose derivatives carrying bulky 
substituents at C-2, we constructed two single point 
mutants and a double mutant that mimic the binding 
site of PNA, expressed them in E. coli, as done by us for 
the recombinant lectin [ 161, and studied their specificity. 
2. MATERIALS AND METHODS 
2.1. Materials 
Native ECorL from mature dry seeds was prepared by affinity 
chromatography on lactose-Sepharose [6]. Vent DNA Polymerase 
was from New England Biolabs; pCR-1000 was from Invitrogen (San- 
Diego, CA) and other enzymes were from Amersham Corp. (Bucking- 
hamshire, England), Pharmacia (Uppsala, Zweden) and New England 
Biolabs (Beverly, MA). Polyclonal antibodies against ECorL were 
from rabbits. Goat anti-rabbit alkaline phosphatase conjugate was 
from BioMakor (Rehovot, Israel). DNA sequencing reagents were 
from US Biochemical Corp. (Cleveland, OH). Synthetic oligonucleo- 
tides were prepared by the Chemical Services of the Weizmann Insti- 
tute of Science. Sugars were from commercial sources, of the highest 
purity available. Methyl a- and/?-N-dansylgalactosaminide were a gift 
from Dr. Willy Kinzy (CIBA-GEIGY, Basel). 
2.2. Lectin mutants 
Mutations were done using PCR according to standard methods 
[17], with pUC-ECorL as target [14]. Primary PCRs were performed 
in pairs containing the mismatched oligonucleotide and the corre- 
sponding 3’ or 5’ oligonucleotide. The primer at the 5’ end was the 
standard Ml3 reverse primer [18] and that at the 3’ end was 
TGGGATCCACATGACAGATAATAACTAACGAC located at 
positions 872-896 of the ECorL cDNA [15]. The latter primer contains 
8 additional nucleotides (bold letters) that provide a BamHI restriction 
site. Reactions were performed in a volume of lOO@ containing a PCR 
buffer (20 mM Tris-HCl, pH 8.8, 10 mM KCl, 10 mM (NH&SO,, 2 
mM MgSO,, 0.1% Triton X-100), dNTPs (200 PM each), 50 pmol of 
3’ and 5’ primers, 200 ng plEcL-C (a plasmid containing ECorL 
cDNA) [16], 2.5 U of Vent DNA Polymerase and two drops of mineral 
oil. Twenty five cycles were performed, each consisting of denatura- 
tion at 95°C for 30 s, annealing at 42°C for 40 s, and extension at 72’ C 
for 1 min. The extension time of the last cycle was 10 min to ensure 
that all single-stranded DNA had been copied or re-annealed. 
After completion of the primary PCRs, aliquots of 20 ~1 were size 
fractionated on 1% low melting agarose gel. Each pair of fragments 
of the expected size was cut out from the gel, mixed and heated at 65’C 
in order to melt the agarose. The melted agarose (5 ~1) containing the 
primary fragments erved as target DNA for the secondary PCR with 
the 3’ and 5’ oligonucleotides mentioned above as primers, under the 
same conditions as for the primary reactions. The final mutated PCR 
product was cloned into the vector pCR-1000 [19] following the suppli- 
ers protocol. Confirmation of the mutations was done by sequencing 
of the mutated cDNAs in the corresponding region [20]. The mutant 
cDNAs were cloned into PET-3d by standard ligation methods using 
NcoI-BamHI restriction sites [21]. Expression and re-folding of lectin 
mutants were performed as described for rECorL [16]. Additional 
purification of the bacterially produced lectins was by gel-filtration on 
a Sephadex G-150 column (1.5 x 90 cm) equilibrated with 10 mM 
TrisHCl, pH 7.5, 0.15 M NaCl; elution was with the same buffer. 
Only the slow-migrating peak, which was eluted at approximately the 
same volume as rECorL (-56 kDa), was collected (40-95% of the 
applied protein). The final yield was 337 mg/l. 
2.3. Protein estimation 
Protein was estimated by measurement of absorption at 280 nm, 
using the optical factor for Erythrina cristagalli, which is 1.53 
mg-‘cm2 [22]. 
2.4. Hemagglutinating activity and inhibition of hemagglutination 
These were assayed by the serial dilution method in microtiter plates 
using a suspension of sialidase-treated [9] human type-0 erythrocytes. 
2.5. Lectin-asialofetuin binding assay 
The method employed was essentially as described for the 14 kDa 
,3-galactoside-binding human lectin [23]. Briefly, the native or bacteri- 
ally produced lectins (25(r500 ng) were reacted with asialofetuin (20 
pg) immobilized on a Nunc Maxisorp immunoplate in the presence of 
various concentrations of different sugars, and the bound lectin was 
quantitated by a double antibody method using anti-ECorL rabbit 
antiserum and alkaline phosphatase-conjugated goat anti-rabbit IgG. 
Development was with p-nitrophenyl disodium phosphate. Coating of 
plates with asialofetuin was overnight at 4°C blocking was with 0.5% 
bovine serum albumin in phosphate-buffered saline (PBS; 10 mM 
KH,PO,, 0.04 M Na,HPO,, 0.9% NaCl, pH 7.4) and washings after 
each step were done with PBS. The concentration of sugar required 
for 50% inhibition (I,,) was calculated, taking the quantity of lectin 
bound in the absence of inhibitor as 100%. 
2.6. Electrophoretic techniques 
SDS-PAGE was performed according to the method of Laemmli 
[24] with 4% stacking gel and 12% separating gel. Electrophoretic 
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transfer of proteins from the gel to the nitrocelhtlose membrane was 
according to Nielsen et al. [25] and was followed by immunodetection. 
The polyclonal anti-ECorL antibody was detected with alkaline phos- 
phataseconjugated goat anti-rabbit antibody, followed by develop- 
ment with 5-bromo-4-chloro-indole-phosphate nd nitro-blue tetra- 
zolium. 
2.7. SpectrofEuorimetric titrations 
These were performed at 23°C with MeaGalNDns and MepGal- 
NDns, as described [7]. 
3. RESULTS AND DISCUSSION 
Upon SDS-PAGE (Fig. 2) the L2, Y108T and 
L2;Y 108T mutants (which are devoid of carbohydrate) 
migrated as single or double bands close to rECorL 
(apparent A& 28 kDa), but somewhat slower than the 
native lectin (apparent M, 30 kDa) which is a glycopro- 
tein (Fig. 2). It should be noted that purified native 
Erythrina lectins often give two closely migrating bands 
on SDS-PAGE [6,26]. This is probably due to C-termi- 
nal processing of the lectins, which occurs both in the 
plant and in E. coli (N.M. Young, private communica- 
tion). The mutants reacted with the polyclonal (Fig. 2) 
as well as with a monoclonal (data not shown) anti- 
ECorL antibody [27], and bound to immobilized asia- 
lofetuin, as did native and recombinant ECorL. They 
had the same hemagglutinating activity as ECorL or 
rECorL (Table I). As sialidase-treated human erythro- 
cytes expose galactose residues on their surface, it 
would appear that no major alterations in the affinity 
of the mutants for galactose occurred with the amino 
acid changes. This conclusion is supported by the re- 
sults of the inhibition of hemagglutination and of the 
binding of the lectin to asialofetuin, which show that the 
affinity of the different lectins for galactose was the 
same, within experimental error (Table II). In both as- 
says Y 108T bound N-acetylgalactosamine and 
-m 
/ 
12 3 4 5 Ml2345 
Fig. 2. SDS-PAGE and Western blot of ECorL, rECorL and its 
mutants. L&ins (3-5 fig), obtained from inclusion bodies and purified 
on Sephadex G-150, were analyzed by electrophoresis on a 12% SDS- 
PAGE and stained either with Coomassie brilliant blue (A) or trans- 
ferred to nitrocellulose membrane and probed with polyclonal rabbit 
anti-ECorL antibodies (B). Lanes: 1, native ECorL (extracted from 
seeds); 2, rECorL; 3, L2; 4, Y108T; 5, L2;Y108T, M, molecular weight 
markers: bovine serum albumin, 67 kDa; ovalbumin, 43 kDa; carbonic 
anhydrase, 30 kDa; trypsin inhibitor, 21.5 kDa; lysozyme 14.3 kDa. 
Table I 
Hemagglutinating activity of ECorL and the bacterially produced 
mutants and their inhibition by different sugars 
Lectin MHC” Gal(MIC)b Relative inhibitor activity’ 
GalNAc MepGalNDns 
ECorL 5.3 25 2 500 
rECorL 5.5 25 2 400 
Y108T 3.9 12.5 2 400 
L2 5.7 12.5 0.5 43 
L2;Y108T 5.8 12.5 0.5 20 
a MHC, minimal ectin concentration @g/ml) that gives hemagglutina- 
tion; in different assays this value ranged between ld@ml, but was 
always the same for rECorL and the mutants, as for ECorL. 
b MIC, minimal sugar concentration (mM) that gives inhibition. 
’ The inhibitory activity of galactose has been arbitrarily set to 1. 
Me/?GalNDns similarly to ECorL and rECorL. Re- 
markably, L2 and L2;Y 108T bound these compounds 
about 2- to 4-times and lo-times weaker, respectively. 
The decrease in affinity of the latter two mutants for 
dansyl-substituted galactosamine was confirmed in the 
spectrofluorimetric binding assay (Table III). The re- 
sults showed that the association constants of MeaGal- 
NDns and MeBGalNDns with Y 108T were only 1.3- to 
2.7-times lower than with rECorL, whereas with L2 and 
L2;Y 108T they were markedly lower, up to 43-times for 
L2 and MeaGalNDns. The slight binding preference of 
rECorL and the mutants for the ol-anomer is constant. 
Also, the molar fluorescence change of the dansyl deriv- 
atives seems to be unaffected by the mutations, indicat- 
ing that the environment in the cavity remained hydro- 
phobic [7], and is similar to that observed in Erythrina 
cristagulli lectin [22]. 
We have thus been able to modifiy the specificity of 
ECorL for GalNAc and GalNDns by site-directed mut- 
agenesis. The results also show that loop 2 of the com- 
bining region of ECorL is responsible for the enhanced 
binding of galactose derivatives with bulky groups 
(acetamido or dansylamido) at C-2 displayed by this 
lectin. Our data give us ground to believe that the differ- 
ences in sugar specificity of ECorL and SBA on the one 
Table II 
Comparison of the I,,” of different sugars with ECorL, rECorL and 
its mutants, measured by a lectin-asialofetuin binding assay 
Lectin Gal GalNAc MgGalNDns 
ECorL 5.70 f 0.52 2.13 + 0.85 0.036 + 0.01 
rECorL 4.42 f 0.66 1.32 + 0.33 0.016 + 0.01 
Y108T 6.30 f 0.57 2.60 + 0.52 0.022 + 0.01 
L2 5.43 f 1.8 10.13 f 0.32 0.23 f 0.07 
L2;Y 108T 7.10 f 1.0 4.60 f 0.5 0.19 f 0.09 
a I,, = concentration (mM) required for 50% inhibition of the binding 
of the lectin to asialofetuin. 
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Table III 
Characteristics for binding of MeaGalNDns and MepGaINDns with ECorL, rECorL and its mutants 
Lectin 
ECorL 
rECorL 
Yl08T 
L2 
L2;Y 108T 
AFl 
3.15 
3.91 
3.92 
3.14 
3.87 
MeaGalNDns 
K, x 1o-5 
W-‘1 
3.58 
2.16 
1.31 
0.084 
0.206 
MG 
(kcaI.mol-‘) 
_ 
0 
0.30 
1.94 
1.10 
AFl 
5.36 
5.50 
4.90 
4.21 
5.49 
Me/?GalNDns 
K, x lo-’ MG 
(M-‘) (kcalmol-‘) 
1 .oo 
1.16 0 
0.78 0.24 
0.056 1.81 
0.12 1.35 
MG 
0.76 
0.37 
0.31 
0.32 
0.32 
The titration parameters, AFl (relative increase in ligand fluorescence) and K. (association constant) were obtained by simulation of the titration 
curve, that corresponds to a simple binding equilibrium. AG’ (at 23’C) = R&K,; MC’ is the difference in binding free energies between a mutant 
lectin and rECorL or, for a given lectin, between the p and a anomers. 
hand and of PNA (at the primary subsite) on the other 
are largely due to steric hindrance by the additional 
amino acids present in loop 2 of the sugar binding site 
of the latter lectin. 
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